LMAT
LEMAITRE VASCULAR INC
Key Financials
Net Income
$57.7M
↑ 31.1%
Operating Income
$67.9M
↑ 30.0%
Revenue
$249.6M
↑ 13.5%
Gross Profit
$178.5M
↑ 18.3%
Total Liabilities
$222.2M
↑ 3.6%
EPS (Diluted)
$2.52
↑ 30.6%
Total Assets
$615.7M
↑ 11.6%
Shareholders' Equity
$393.5M
↑ 16.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 9/8/2026 | View on SEC |
| 4 | 9/8/2026 | View on SEC |
| 4 | 9/8/2026 | View on SEC |
| 4 | 9/8/2026 | View on SEC |
| 4 | 9/8/2026 | View on SEC |
| 4 | 9/8/2026 | View on SEC |
| 4 | 9/8/2026 | View on SEC |
| 4 | 9/8/2026 | View on SEC |
| 4 | 9/8/2026 | View on SEC |
| 4 | 9/3/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LMAT |
| Company Name | LEMAITRE VASCULAR INC |
| CIK | 1158895 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 781-221-2266 |